Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial. Wickström A, Dahle C, Vrethem M, Svenningsson A Mult Scler. 2013 Dec 30. PMID: 24378984. Abstract CommentRecommendBookmarkWatch